Nutranomics, Inc.
NNRXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$816232
P/E Ratio—
52W High$0.0001
52W Low$0.00005
Nutranomics, Inc. (NNRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NNRX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-07 | 2021-07 | 2020-07 | 2019-07 | 2015-07 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.85M | $1.76M | $0.00M | $0.06M | $1.79M |
| Cost of Revenue | $5.92M | $2.82M | $0.00M | $0.04M | $0.90M |
| Gross Profit | ($3.08M) | ($1.06M) | ($0.00M) | $0.02M | $0.89M |
| Gross Margin %(computed) | -108.05% | -60.39% | -46.73% | 36.22% | 49.67% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.41M | $0.51M | $1.65M |
| Total Operating Expenses | $5.39M | $0.78M | $0.60M | $0.60M | $1.72M |
| Operating Income | ($8.47M) | ($1.83M) | ($0.60M) | ($0.57M) | ($0.84M) |
| Operating Margin %(computed) | -297.40% | -103.90% | — | -963.34% | -46.73% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.46M | $0.05M | $0.30M | $0.68M | $0.47M |
| Income Before Tax | ($6.63M) | ($1.88M) | ($0.95M) | ($2.24M) | ($1.22M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.00M) | $0.00M |
| Net Income | ($6.63M) | ($1.89M) | ($0.95M) | ($2.24M) | ($1.22M) |
| Net Margin %(computed) | -232.89% | -107.50% | — | — | -68.04% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 9589.05M | 5913.82M | 3725.47M | 1390.62M | 112.43M |
| EBITDA | ($4.01M) | ($1.57M) | ($0.60M) | ($1.56M) | ($0.74M) |
| EBITDA Margin %(computed) | -140.96% | -89.18% | — | — | -41.29% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Nutranomics, Inc. data
About Nutranomics, Inc. (NNRX) Income Statement
Nutranomics, Inc. (NNRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, NNRX reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -108.05%), and net income of ($0.01B) — a net profit margin of -232.89%.
Frequently asked questions
NNRX · 4 questionsNutranomics, Inc. (NNRX) reported revenue of $0.00B for 2022, up 62.0% year-over-year.
NNRX revenueNNRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09